ConvaTec Group Plc

ConvaTec Group Plc

CNVVY

$11.30

Updated: 24/09/2026, 16:58:15

Market Cap
$5.52B
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
GB
Stock valuation chart
One-year closing share-price history for CNVVY
Company Profile

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse conditions such as diabetes, immobility, venous disease, traumatic injuries, burns, or complications following surgery. Furthermore, ConvaTec provides comprehensive ostomy care, including specialized devices, accessories, and support services for individuals living with a stoma, often necessitated by conditions like colorectal or bladder cancer, inflammatory bowel disease, obesity, among other medical reasons. Its product portfolio also extends to continence and critical care. This encompasses intermittent urinary catheters and solutions for managing bladder control issues linked to spinal cord injuries, multiple sclerosis, spina bifida, and various other urological disorders. Additionally, the firm supplies medical devices and products specifically designed for use in intensive care units (ICUs) and broader hospital settings. ConvaTec develops sophisticated systems for handling acute fecal incontinence, as well as for precise monitoring of urine production output and intra-abdominal pressure. A diverse array of disposable medical devices is also provided, featuring wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen/aerosol therapy, suction handles and tubing, gastroenterology tubes, and securement devices. The company is also a supplier of disposable infusion sets to manufacturers of insulin pumps for diabetic patients, and similar sets for pumps employed in continuous infusion treatments for other medical conditions. ConvaTec serves a broad spectrum of clients, including healthcare providers, patients, and other manufacturers. Its products reach both hospital and home healthcare markets, distributed through direct sales, as well as via distributors and wholesalers, targeting pharmacies, hospitals, and various acute and post-acute healthcare service providers. Established in 1978, the company's corporate headquarters are located in Reading, United Kingdom.

USD
OTC
CEO: Jonathan Peter Mason
Employees: 10,910
https://www.convatecgroup.com
Asset Summaries
Latest generated summaries for CNVVY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for CNVVY.
Share price
$11.30
Market cap
$5.52B
Exchange
OTC
Currency
USD
CEO
Jonathan Peter Mason
Employees
10,910
IPO date
26/01/2017
Beta
0.84
Last dividend
$0.00
Day range
$11.30 – $11.30
52-week range
$10.45 – $14.09
1-day performance
-1.31%
1-year performance
8.13%
Current drawdown (1Y)
-19.82%
CIK
N/A
CUSIP
21244X109
ISIN
US21244X1090
Created
07/12/2025, 03:23:25
Last update
24/09/2026, 16:58:15

Track ConvaTec Group Plc with an AI analyst

See which prediction-market events move CNVVY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.